TABLE 3.
Direct Multiplex-PCR analysis of 18 commercially available product samples with declared content of bifidobacteria (samples 1 to 4 and 6 to 18), lactobacilli (sample 5), or other LABb
Sample no. | PCR results
|
||
---|---|---|---|
Bflact2-Bflact5 | Lm3-P0a | P0-338F | |
1 | + | ± | + |
2 | + | ± | + |
3 | − | + | + |
4 | − | + | + |
5 | − | − | + |
6 | + | ± | + |
7 | + | ± | + |
8 | − | + | + |
9 | − | + | + |
10 | + | ± | + |
11 | + | ± | + |
12 | + | ± | + |
13 | + | ± | + |
14 | + | ± | + |
15 | + | ± | + |
16 | − | + | + |
17 | − | + | + |
18 | − | + | + |
±, PCR results after a run of 25 cycles. For B. lactis, a competitive reaction between the resulting PCR amplicons for the species B. lactis and the genus Bifidobacterium might occur (primer pair Bflact2-Lm3).
LAB, lactic acid bacteria.